Ninth Case of Rare Blood Clotting After Administration of AstraZeneca Reported in Quebec


Quebec reports the ninth case of rare blood clotting after the administration of the AstraZeneca vaccine. The Ministry of Health and Social Services revealed on Tuesday news releases that the case involved a woman.

The woman’s age has not been revealed, but the health and social services in charge affirmed that she has received appropriate care and is currently recovering at home.

According to health officials, cases of blood clots are rare, but they are potentially lethal and should be monitored. The risk of experiencing blood clots after the first dose stands at one case in 50, 000 doses. For the second dose, the risk is further lower, one case in every 600,000 doses.

The health ministry is requesting anyone who has received a dose of AstraZeneca and experiencing: shortness of breath, chest pain, swelling legs, severe headache, stomach pain, blurred vision, or bruises on the skin to contact their doctor or Info-Sante.

In April, a Canadian woman died after experiencing a blood clot related to the AstraZeneca vaccine. That was the first reported case of death due to the administration of the vaccine in Canada.


Please enter your comment!
Please enter your name here